Atlantic Research Group

Atlantic Research Group

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Atlantic Research Group (ARG) is a specialized Contract Research Organization (CRO) with a strong track record in managing complex clinical trials, particularly in oncology, immunology, and neurology. The company emphasizes a flexible, collaborative approach and boasts a high rate of repeat business. Its recent merger with Evestia Clinical positions it as part of a larger, global specialist CRO aiming to enhance service capabilities and geographic reach.

OncologyImmunologyNeurology

Technology Platform

Integrated clinical trial operational processes with a focus on customization and exploration of generative AI applications.

Opportunities

The merger creates a larger global specialist CRO with enhanced capabilities to compete for complex trials in high-growth therapeutic areas like oncology and neurology.
Growing biopharma R&D outsourcing and the integration of advanced technologies like AI present significant expansion opportunities.

Risk Factors

Key risks include post-merger integration challenges, potential client or talent attrition, intense competition in the CRO market, and operational risks associated with managing complex clinical trials.
The business is also dependent on the R&D spending cycles of its biopharma clients.

Competitive Landscape

ARG operates in the highly competitive global CRO market, competing with large full-service CROs (IQVIA, PPD, ICON) and smaller niche players. Its differentiator has been a flexible, therapeutic-area-focused approach, a position now amplified through its merger to create a scaled specialist competitor.